logo
EVALUATION OF THE THROMBOXANE A2 SYNTHETASE INHIBITOR OKY-046 IN A WARM ISCHEMIA-REPERFUSION RAT MODEL1
ABNORMAL IN VIVO RESPONSE TO SODIUM NITROPRUSSIDE AFTER PORCINE SINGLE LUNG TRANSPLANTATION1
PREVENTION OF CHRONIC REJECTION BY DONOR-SPECIFIC BLOOD TRANSFUSION IN A NEW MODEL OF CHRONIC CARDIAC ALLOGRAFT REJECTION1
THE PAF ANTAGONIST TCV-309 REDUCES GRAFT PMN INFILTRATION AND ENHANCES EARLY FUNCTION OF 24-HOUR-PRESERVED RAT KIDNEYS WITH LONG WARM ISCHEMIA
EFFECT OF TACROLIMUS ON HEMODYNAMICS AND ABSORPTION OF EXPERIMENTAL SMALL INTESTINAL TRANSPLANTS1
SMALL BOWEL ALLOGRAFT REJECTION DETECTED BY SERUM INTESTINAL FATTY ACID-BINDING PROTEIN IS REVERSIBLE
T AND B CELL RESPONSIVENESS TO DONOR CLASS I MHC MOLECULES AND PEPTIDES IN LONG SURVIVORS WITH KIDNEY ALLOGRAFTS1
ACUTE GRAFT REJECTION OF HUMAN FETAL PANCREAS ALLOGRAFTS USING DONOR-SPECIFIC HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN THE SCID MOUSE1
DETECTION OF IGA ANTI-OKT3 ANTIBODIES IN OKT3-TREATED TRANSPLANT RECIPIENTS1
THE EFFECT OF PRAVASTATIN ON ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION-A PILOT STUDY1
DIABETES MELLITUS AFTER RENAL TRANSPLANTATION
PATIENT DEATH AFTER RENAL TRANSPLANTATION-AN ANALYSIS OF ITS ROLE IN GRAFT OUTCOME1
A PILOT STUDY OF RIBAVIRIN THERAPY FOR RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION1
TRANSPLANTATION FOR END STAGE LIVER DISEASE RELATED TO ALPHA 1 ANTITRYPSIN
PREVENTION OF BONE LOSS IN CARDIAC TRANSPLANT RECIPIENTS
HEPATIC RETRANSPLANTATION-AN ANALYSIS OF RISK FACTORS ASSOCIATED WITH OUTCOME1
CLINICALLY RELEVANT DOSES AND BLOOD LEVELS PRODUCE EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY WHEN COMBINED WITH NITRIC OXIDE INHIBITION1
EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX VIVO XENOGENEIC PERFUSION MODEL1,2
THE EFFECT OF COMBINATION SPLENECTOMY AND LOW-DOSE FK506 THERAPY ON GRAFT SURVIVAL AFTER LIVER ALLOGRAFT TRANSPLANTATION IN RATS
RECOVERY OF BLOOD MONONUCLEAR CELL CALCINEURIN ACTIVITY SEGREGATES TWO POPULATIONS OF RENAL TRANSPLANT PATIENTS WITH DIFFERENT SENSITIVITIES TO CYCLOSPORINE INHIBITION
RECIPIENT CELLS EXPRESSING SINGLE DONOR MHC LOCUS PRODUCTS CAN SUBSTITUTE FOR DONOR-SPECIFIC TRANSFUSION IN THE INDUCTION OF TRANSPLANTATION TOLERANCE WHEN PRETREATMENT IS COMBINED WITH ANTI-CD4 MONOCLONAL ANTIBODY
THE USE OF MAGNETIC BEADS COATED WITH SOLUBLE HLA CLASS I OR CLASS II PROTEINS IN ANTIBODY SCREENING AND FOR SPECIFICITY DETERMINATION OF DONOR-REACTIVE ANTIBODIES1
RENAL ALLOGRAFT REJECTION-IN SITU DEMONSTRATION OF CYTOTOXIC INTRATUBULAR CELLS1
SUCCESSFUL RENAL TRANSPLANTATION FROM TWO DONORS WITH METHANOL INTOXICATION
A CASE REPORT OF PREGNANCY IN A RENAL TRANSPLANT RECIPIENT TREATED WITH FK506(TACROLIMUS)
IMPROVED ISLET ISOLATION FROM RAT PANCREAS USING 35% BOVINE SERUM ALBUMIN IN COMBINATION WITH DEXTRAN GRADIENT SEPARATION